Literature DB >> 25334018

Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α.

Jie Liu1, Xiao-Cheng Cao2, Qiao Xiao2, Mei-Fang Quan2.   

Abstract

The protein kinase casein kinase 2 (CK2) has been implicated in stem cell maintenance and its aberrant activation has been demonstrated in several types of cancer, including cervical cancer. In the present study, it was demonstrated that the sphere-forming cells (SFCs) of HeLa cell lines exhibited self-renewal capacity, indicating that they possessed the properties of cervical cancer stem-like cells. HeLa-derived SFCs exhibited a higher level of CK2α protein, compared with the parental cells. Apigenin, a dietary flavonoid, led to a dose-dependent inhibition of the self-renewal capacity and the protein expression of CK2α in HeLa-derived SFCs. Furthermore, forced overexpression of CK2α resulted in a decrease in the inhibition of CK2α expression and the self-renewal capacity induced by apigenin in HeLa-derived SFCs. These results suggested that apigenin inhibits the self-renewal capacity of HeLa-derived SFCs through downregulation of CK2α expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25334018     DOI: 10.3892/mmr.2014.2720

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  18 in total

Review 1.  Cervical cancer stem cells: opportunities and challenges.

Authors:  Ravindresh Chhabra
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-07       Impact factor: 4.553

2.  Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.

Authors:  Amber L Rowse; Sara A Gibson; Gordon P Meares; Rajani Rajbhandari; Susan E Nozell; Kory J Dees; Anita B Hjelmeland; Braden C McFarland; Etty N Benveniste
Journal:  J Neurooncol       Date:  2017-02-08       Impact factor: 4.130

3.  Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.

Authors:  Suat Erdogan; Kader Turkekul; Ilker Dibirdik; Zeynep B Doganlar; Oguzhan Doganlar; Ayhan Bilir
Journal:  Invest New Drugs       Date:  2019-04-16       Impact factor: 3.850

4.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

5.  Oxidative Stress Triggered by Apigenin Induces Apoptosis in a Comprehensive Panel of Human Cervical Cancer-Derived Cell Lines.

Authors:  Raquel P Souza; Patrícia de S Bonfim-Mendonça; Fabrícia Gimenes; Bianca A Ratti; Vanessa Kaplum; Marcos L Bruschi; Celso V Nakamura; Sueli O Silva; Silvya S Maria-Engler; Marcia E L Consolaro
Journal:  Oxid Med Cell Longev       Date:  2017-01-16       Impact factor: 6.543

Review 6.  Apigenin in cancer therapy: anti-cancer effects and mechanisms of action.

Authors:  Xiaohui Yan; Miao Qi; Pengfei Li; Yihong Zhan; Huanjie Shao
Journal:  Cell Biosci       Date:  2017-10-05       Impact factor: 7.133

Review 7.  CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.

Authors:  Melissa M J Chua; Charina E Ortega; Ayesha Sheikh; Migi Lee; Hussein Abdul-Rassoul; Kevan L Hartshorn; Isabel Dominguez
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-28

Review 8.  Targeted Gene Delivery Therapies for Cervical Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Houria Boulaiz
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 9.  Compounds from Natural Sources as Protein Kinase Inhibitors.

Authors:  Andrea Baier; Ryszard Szyszka
Journal:  Biomolecules       Date:  2020-11-12

Review 10.  Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer.

Authors:  Milad Ashrafizadeh; Mohammad Reza Bakhoda; Zahra Bahmanpour; Khandan Ilkhani; Ali Zarrabi; Pooyan Makvandi; Haroon Khan; Samaneh Mazaheri; Maryam Darvish; Hamed Mirzaei
Journal:  Front Chem       Date:  2020-10-15       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.